Braille Teach is a device with audio feedback to help blind and visually impaired people learn the Braille alphabet.
Nowadays AI, Robots and automation are trend, but very soon autonomous devices, car and other machines will be everywhere at our daily life. From our over the horizon vision, "Horizon Next" team is bringing innovation to life, aiming equal and wealth life for humans.
C2N Diagnostics, LLC is a privately held company focused on protein diagnostics and therapeutic discovery for progressive neurodegenerative diseases, particularly Alzheimer's disease. Founded in late 2007 by Drs. David Holtzman and Randall Bateman from Washington University School of Medicine, alongside LifeTech Research, the company is based at the Center for Emerging Technologies in St. Louis. C2N Diagnostics utilizes advanced mass spectrometry techniques to offer precise identification, quantification, and monitoring of proteins and biomolecules associated with neurological disorders. This innovative approach enables healthcare professionals to detect and characterize neurocognitive disorders more accurately, enhancing the potential for effective diagnosis and treatment strategies.